Select Publications
Conference Papers
2006, 'Differential expression of pyloric atresia in junctional epidermolysis bullosa with novel ITGB4 mutations', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Melbourne, pp. 2692 - 2692, presented at 3RD ANNUAL MEETING OF THE AUSTRALASIAN-SOCIETY-FOR-DERMATOLOGY-RESEARCH, AUSTRALIA, Melbourne, 13 May 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250226800074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Novel and recurrent mutations in KRT5 and KRT14 in epidermolysis bullosa simplex in Australia', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Melbourne, pp. 2690 - 2690, presented at 3RD ANNUAL MEETING OF THE AUSTRALASIAN-SOCIETY-FOR-DERMATOLOGY-RESEARCH, AUSTRALIA, Melbourne, 13 May 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250226800069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Review of collagen VII mutations found in Australian patients with dystrophic epidermolysis bullosa reveals 9 novel COL7A1 mutations', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Melbourne, pp. 2691 - 2691, presented at 3RD ANNUAL MEETING OF THE AUSTRALASIAN-SOCIETY-FOR-DERMATOLOGY-RESEARCH, AUSTRALIA, Melbourne, 13 May 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250226800070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2003, 'Molecular analysis of the glomulin gene in glomuvenous malformation families', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, CALIFORNIA, LOS ANGELES, pp. 571 - 571, presented at Annual Meeting of the American-Society-of-Human-Genetics, CALIFORNIA, LOS ANGELES, 04 November 2003 - 08 November 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185599702366&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Posters
2015, 'Periumbilical thumbprint parasitic purpura: A highly fatal sign in disseminated Strongyloides infection that may mimic vasculitis clinically', California, Vol. 72, presented at American Academy of Dermatologists 73rd Annual Meeting,, California, 20 March 2015 - 24 March 2015
,Conference Presentations
2021, 'Lymphocytic fibroinflammation with IgG4 modifies the phenotype of eczema and alopecia', presented at St John's Institute of Dermatology Grand Rounds, London, 04 February 2021 - 04 February 2021
,2019, 'A review of Patient Travel Assistance Schemes (PTAS) guidelines for rural dermatology patients in Australia.', presented at 2019 Australasian College of Dermatologists Rural Dermatology Meeting, Orange, New South Wales, Australia, 06 September 2019 - 08 September 2019
,2014, 'Marked intrafamilial variability in dystrophic epidermolysis bullosa caused by dominant and recessive COL7A1 mutations', presented at 44th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), DENMARK, Copenhagen, 10 September 2014 - 13 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000340352100335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Responsiveness of the Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) to therapies in epidermolysis bullosa and epidermolysis bullosa acquisita', presented at 44th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), DENMARK, Copenhagen, 10 September 2014 - 13 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000340352100238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'A comparison study of outcome measures for atopic dermatitis', presented at 8th Georg Rajka Symposium on Atopic Dermatitis (ISAD), ENGLAND, Nottingham, 21 May 2014 - 23 May 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337952200025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts', http://dx.doi.org/10.1016/j.jaad.2014.08.024
,2009, 'Retrospective Evidence on Outcomes and Experiences of Pregnancy and Childbirth in Epidermolysis Bullosa in Australia and New Zealand', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271495600045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Abstracts
2022, 'BASELINE DEMOGRAPHICS, COMORBIDITIES, AND TREATMENT PATTERNS IN ASIAN ADULTS WITH ATOPIC DERMATITIS WHO RECEIVED DUPILUMAB IN A REAL-WORLD SETTING', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 7 - 8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862654200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Sebaceous cell carcinoma presenting as an ocular Marjolin ulcer following exposure to a common alkaline cleaning agent', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, Vol. 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000844437002198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, '194 Patient-reported disease burden in epidermolysis bullosa simplex (EBS)', in Journal of Investigative Dermatology, Elsevier BV, Vol. 142, pp. S33 - S33, http://dx.doi.org/10.1016/j.jid.2022.05.201
,2022, '311 Treatment of bullous pemphigoid by inhibiting fcrn: Pre-registration report of a phase 2/3 trial with efgartigimod', in Journal of Investigative Dermatology, Elsevier BV, Vol. 142, pp. S53 - S53, http://dx.doi.org/10.1016/j.jid.2022.05.319
,2021, 'A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 141, pp. S28 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800157&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease (AIBD) using the Glucocorticoid Toxicity Index (GTI)', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 141, pp. S72 - S72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800414&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'A systematic review of drug-induced pemphigoid', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 133 - 134, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Allopurinol induced DRESS in Han Chinese - is routine HLA-B*58:01 genotyping warranted?', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 115 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700285&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Blurred lines: the benefits, risks, and challenges of sharing digital images for dermatological consultation', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 110 - 110, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Low dose naltrexone for Hailey-Hailey disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 114 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Pancreatic adenocarcinoma growth retardation in a psoriasis patient on Ustekinumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 114 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Relationship between pruritus, sleep, and quality of life (QOL) in atopic dermatitis (AD): post hoc analysis of JADE MONO-2', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 124 - 125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700311&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Successful dapsone therapy in inherited Epidermolysis Bullosa', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Successful treatment of hypocomplementaemic urticarial vasculitis syndrome (HUVS) with omalizumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 103 - 103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Successful treatment of hypocomplementaemic urticarial vasculitis syndrome (HUVS) with omalizumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Ustekinumab and tildrakizumab in pyoderma gangrenosum', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 114 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700284&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Which outcome measures are the best for clinical trials in Epidermolysis Bullosa?', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 62, pp. 110 - 111, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630901700273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Results from ADVISE: a randomized, double-blind, placebo-controlled phase II study of etrasimod, an oral, selective, sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis', in BRITISH JOURNAL OF DERMATOLOGY, WILEY, Vol. 184, pp. E85 - E85, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000625508500052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, '415 Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease (AIBD) using the Glucocorticoid Toxicity Index (GTI)', in Journal of Investigative Dermatology, Elsevier BV, Vol. 141, pp. S72 - S72, http://dx.doi.org/10.1016/j.jid.2021.02.438
,2020, 'DIACEREIN 1% OINTMENT FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA SIMPLEX: RESULTS OF A PHASE 2 STUDY', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 46 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'DRY EYE DISEASE IDENTIFIED IN A PROSPECTIVE STUDY OF OCULAR INVOLVEMENT IN EPIDERMOLYSIS BULLOSA AND AUTOIMMUNE BLISTERING DISEASES', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 78 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'EPIDERMOLYSIS BULLOSA RELEVANT ENDPOINTS - A DEBATE', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 15 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'REVIEW OF HAIR DISORDERS AND ALOPECIA IN EPIDERMOLYSIS BULLOSA DISEASE GROUP: A NEGLECTED AREA OF CARE', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'TOPICAL THERAPIES FOR EPIDERMOLYSIS BULLOSA', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'WHICH OUTCOME MEASURES ARE THE BEST FOR CLINICAL TRIALS IN EPIDERMOLYSIS BULLOSA?', in ACTA DERMATO-VENEREOLOGICA, ACTA DERMATO-VENEREOLOGICA, Vol. 100, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000568327600106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Dry eye disease identified in a prospective study of ocular manifestations in Inherited Epidermolysis Bullosa and Autoimmune Blistering Diseases', in CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, WILEY, Vol. 47, pp. 113 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493279000184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Prospective study of the ocular manifestations in Epidermolysis Bullosa and Autoimmune Blistering Diseases identifies Dry Eye Disease', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, CANADA, Vancouver, Vol. 60, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), CANADA, Vancouver, 28 April 2019 - 02 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488800703057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, DC, Washington, Vol. 81, pp. AB99 - AB99, presented at Annual Meeting of the American-Academy-of-Dermatology (AAD), DC, Washington, 01 March 2019 - 05 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000482195001010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Omalizumab shows variable efficacy in the treatment of bullous pemphigoid', in BRITISH JOURNAL OF DERMATOLOGY, WILEY, ENGLAND, RCP, London, Vol. 180, pp. E146 - E147, presented at 14th Annual Medical Dermatology Meeting, ENGLAND, RCP, London, 17 January 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000466806400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'A case-control study on the environmental triggers of autoimmune blistering disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Ocular complications of pemphigus, pemphigoid and epidermolysis bullosa acquisita: A prospective study', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Thalidomide and doxycycline in the management of junctional epidermolysis bullosa laryngo-onycho-cutaneous syndrome (JEB-LOC)', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Updates to scoring tools for grading severity of disease in chronic cutaneous blistering diseases', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 83 - 83, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Urticarial vasculitis dependent on systemic steroids: Complete therapeutic response to omalizumab', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Validation of the BIOCHIP as a diagnostic tool for pemphigus vulgaris and foliaceus in Australia', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 59, pp. 125 - 125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431000100346&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Prospective study on the ocular manifestations in Epidermolysis Bullosa and Autoimmune Blistering Diseases.', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, HI, Honolulu, Vol. 59, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), HI, Honolulu, 29 April 2018 - 03 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000442912500129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'A study of the number of female editors-in-chief of dermatology journals', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 58, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Contributions of the independent learning programme at University of New South Wales to dermatology registrar training 2006-2016', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 58, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,